Screening assays for targets and drugs useful in treatment...

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) C07K 14/435 (2006.01) C12Q 1/26 (2006.01) G01N 33/92 (2006.01)

Patent

CA 2516023

The invention relates to the use of C. elegans as a model for identifying genes that are involved in lipid or lipoprotein metabolism and which can serve as drug targets. The invention also provides a system for screening drugs useful in the treatment and prevention of diseases associated with undesirable or abnormal levels of lipids (e.g., cholesterol) or lipoproteins (e.g., LDL), such as cardiovascular disorders and dyslipidemia.

La présente invention concerne l'utilisation de C.elegansen tant que modèle pour identifier des gènes qui sont impliqués dans le métabolisme des lipides ou des lipoprotéines et qu'on peut utiliser en tant que cibles pour des médicaments. La présente invention se rapporte également à un système de criblage de médicaments utiles dans le traitement et la prévention des maladies associées à des taux défavorables ou anormaux de lipides (par exemple, le cholestérol) ou de lipoprotéines (par exemple LDL) telles que les troubles cardio-vasculaires et la dyslipidémie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Screening assays for targets and drugs useful in treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Screening assays for targets and drugs useful in treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening assays for targets and drugs useful in treatment... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1957116

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.